Related Experiment Video
Updated: May 19, 2026

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice
Published on: July 8, 2020
In search of a better understanding of IgA nephropathy-associated hematuria
Insights
Researchers found that the chemokine receptor CX3CR1 is upregulated in IgA nephropathy (IgAN) patients during hematuria episodes. This suggests CX3CR1 and fractalkine may play a role in causing macroscopic hematuria in IgAN.
Area of Science:
- Nephrology
- Immunology
- Pathogenesis of kidney disease
Background:
- IgA nephropathy (IgAN) is characterized by hematuria, but its pathogenesis remains unclear.
- Understanding the mechanisms behind IgAN-related hematuria is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the role of chemokine signaling in IgA nephropathy (IgAN) during episodes of macroscopic hematuria.
- To identify potential molecular players involved in the onset of hematuria in IgAN patients.
Main Methods:
- Studied IgA nephropathy patients during episodes of macroscopic hematuria.
- Analyzed the expression of chemokine receptors in circulating leukocytes.
- Conducted experimental approaches to assess the function of CX3CR1 and fractalkine.
Main Results:
- Identified upregulated expression of the chemokine receptor CX3CR1 in circulating leukocytes of IgAN patients during hematuria.
- Experimental data suggest a contribution of the CX3CR1/fractalkine axis to macroscopic hematuria in IgAN.
Conclusions:
- The CX3CR1/fractalkine pathway is implicated in the pathogenesis of macroscopic hematuria in IgA nephropathy.
- Targeting this pathway may offer a novel therapeutic strategy for IgAN patients experiencing hematuria.
Abstract:
Although microscopic or episodic macroscopic hematuria is the key clinical manifestation of IgA nephropathy (IgAN), still very little is known about its pathogenesis. Cox et al. studied IgAN patients during episodes of macroscopic hematuria and identified an upregulated expression of the chemokine receptor CX3CR1 in their circulating leukocytes. On the basis of a series of additional experimental approaches, they suggest that CX3CR1 and its ligand fractalkine may contribute to the onset of macroscopic hematuria in IgAN.
More Related Videos
Related Concept Videos
Urine Studies I: Urinalysis
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome I : Introduction
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Pyelonephritis II: Diagnostic Studies and Management

